Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cleveland Biolabs Inc (NASDAQ:CBLI)

1.60
Delayed Data
As of Dec 08
 -0.0014 / -0.09%
Today’s Change
1.45
Today|||52-Week Range
4.17
-54.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues1.3M812.5K575.0K1.1M
 
 
 
 
 
Depreciation And Amortization--26.6K14.9K12.1K
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses3.1M3.1M2.1M1.8M
 
 
 
 
 
Other Operating Expenses1.1M0.000.000.00
 
 
Research And Development1.9M1.9M1.3M1.1M
 
 
 
 
 
Total Operating Expenses4.1M3.1M2.1M1.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.9M-2.3M-1.5M-714.1K
 
 
 
 
 
Extraordinary Credit0.001.4M0.001.8M
 
 
 
Extraordinary Charge0.000.00-547.2K--
 
 
Other Expenses1.2M47.1K33.1K10.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.7M-670.7K-1.9M1.1M
 
 
 
 
 
Minority Interest-246.2K-2.8K-11.5K-2.1K
 
 
 
 
 
Net Income-1.4M-667.9K-1.9M1.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.8M11.0M11.0M11.0M
 
 
 
 
 
Shares To Calculate EPS Diluted10.8M11.0M11.0M11.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.13-$0.06-$0.17$0.10
 
 
 
 
 
EPS Diluted-$0.13-$0.06-$0.17$0.10